Imricor Adds Virginia Commonwealth University as Third U.S. Site in VISABL-AFL Trial

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:IMR) ) has issued an update.

Imricor Medical Systems has secured Institutional Review Board approval for Virginia Commonwealth University Health to join its VISABL-AFL clinical trial, making VCU Health the third U.S. site participating in the study supporting U.S. FDA approval of Imricor’s cardiac ablation products. With budgeting, installation and training expected to conclude in February and procedures slated to begin in March under Principal Investigator Dr Ajay Pillai, the addition of a large, nationally ranked academic health system underscores growing clinical interest in Imricor’s MRI‑guided NorthStar mapping system and Vision-MR mapping and ablation catheters, and marks a further step in advancing its U.S. regulatory and commercial positioning in cardiac ablation.

The most recent analyst rating on (AU:IMR) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:IMR Stock Forecast page.

More about Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Imricor Medical Systems, Inc. is a medical technology company focused on making interventional procedures better, safer and more cost effective by enabling them to be performed under real-time MRI guidance instead of x-ray fluoroscopy, leveraging MRI’s superior imaging capabilities. The company is a pioneer in MRI‑compatible products for cardiac catheter ablation, offering capital equipment such as the NorthStar Mapping System and Advantage‑MR EP Recorder/Stimulator, as well as single-use ablation and diagnostic catheters, steerable sheaths and related tools. Imricor’s products are currently approved in the European Union, Saudi Arabia and New Zealand, with U.S. FDA approval in process and additional geographic approvals, including Australia, planned.

Average Trading Volume: 204,014

Technical Sentiment Signal: Buy

Current Market Cap: A$602.4M

See more data about IMR stock on TipRanks’ Stock Analysis page.